166
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Impact of the COVID-19 Pandemic on Incidence and Short-Term Survival for Common Solid Tumours in the United Kingdom: A Cohort Analysis

ORCID Icon, , ORCID Icon, , , , ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon & show all
Pages 417-429 | Received 14 Mar 2024, Accepted 22 May 2024, Published online: 11 Jun 2024

References

  • Machii R, Takahashi H. Japanese cancer screening programs during the COVID-19 pandemic: changes in participation between 2017-2020. Cancer Epidemiol. 2023;82:102313. doi:10.1016/j.canep.2022.102313
  • Alkatout I, Biebl M, Momenimovahed Z, et al. Has COVID-19 affected cancer screening programs? A systematic review. Front Oncol. 2021;11:675038. doi:10.3389/fonc.2021.675038
  • Barclay NL, Pineda-Moncusí M, Jödicke AM, et al. The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study. MedRxiv. 2023. doi:10.1101/2023.07.21.23292937
  • Cancer Research UK. Cancer mortality statistics. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/mortality#heading-Zero. Accessed September 28, 2023.
  • Rashid T, Bennett JE, Muller DC, et al. Mortality from leading cancers in districts of England from 2002 to 2019: a population-based, spatiotemporal study. Lancet Oncol. 2023;25:86–98. doi:10.1016/S1470-2045(23)00530-2
  • Arnold M, Rutherford MJ, Bardot A, et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019;20(11):1493–1505. doi:10.1016/S1470-2045(19)30456-5
  • Alderwick H. Is the NHS overwhelmed? BMJ. 2022;376:051. doi:10.1136/bmj.o51
  • Carr A, Smith JA, Camaradou J, Prieto-Alhambra D. Growing backlog of planned surgery due to covid-19. BMJ. 2021;2021:372.
  • McLellan A, Abbasi K. The NHS is not living with covid, it’s dying from it. BMJ. 2022;2022:378.
  • Maringe C, Spicer J, Morris M, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. 2020;21(8):1023–1034. doi:10.1016/S1470-2045(20)30388-0
  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
  • Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: clinical practice research Datalink (CPRD). Int J Epidemiol. 2015;44(3):827–836. doi:10.1093/ije/dyv098
  • Voss EA, Makadia R, Matcho A, et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. 2015;22(3):553–564. doi:10.1093/jamia/ocu023
  • Gilbert J, Rao G, Schuemie M, Ryan P, Weaver J. CohortDiagnostics: diagnostics for OHDSI Cohorts. Available from: https://ohdsi.github.io/CohortDiagnostics. Accessed 2, August 2023.
  • Gallagher AM, Dedman D, Padmanabhan S, Leufkens HG, de Vries F. The accuracy of date of death recording in the clinical practice research Datalink GOLD database in England compared with the office for national statistics death registrations. Pharmacoepidemiol Drug Saf. 2019;28(5):563–569. doi:10.1002/pds.4747
  • Eurostat Taskforce. Revision of the European Standard Population - Report of Eurostat’s task force. Available from: https://ec.europa.eu/eurostat/web/products-manuals-and-guidelines/-/ks-ra-13-028. Accessed August 2, 2023.
  • Mazidimoradi A, Hadavandsiri F, Momenimovahed Z, Salehiniya H. Impact of the COVID-19 pandemic on colorectal cancer diagnosis and treatment: a systematic review. J Gastrointest Can. 2021;2021:1–17.
  • Cancer Research UK. Cancer incidence for all cancers combined. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence/all-cancers-combined. Accessed August 9, 2023.
  • Strongman H, Williams R, Bhaskaran K. What are the implications of using individual and combined sources of routinely collected data to identify and characterise incident site-specific cancers? A concordance and validation study using linked English electronic health records data. BMJ open. 2020;10(8):e037719. doi:10.1136/bmjopen-2020-037719
  • Maddams J, Utley M, Moller H. Projections of cancer prevalence in the United Kingdom, 2010-2040. Br J Cancer. 2012;107(7):1195–1202. doi:10.1038/bjc.2012.366
  • Bennett R, Blanks R, Moss S. Evaluation of extension of breast screening to women aged 65–70 in England using screening performance measures. Br J Cancer. 2009;100(7):1043–1047. doi:10.1038/sj.bjc.6604981
  • Mora N, Guiriguet C, Cantenys R, et al. Cancer diagnosis in primary care after second pandemic year in Catalonia: a time-series analysis of primary care electronic health records covering about 5 million people. Family Practice. 2023;40(1):183–187. doi:10.1093/fampra/cmac083
  • Skovlund CW, Friis S, Dehlendorff C, Nilbert MC, Mørch LS. Hidden morbidities: drop in cancer diagnoses during the COVID-19 pandemic in Denmark. Acta oncologica. 2021;60(1):20–23. doi:10.1080/0284186X.2020.1858235
  • Nindenshuti PM, Caire-Juvera G. Changes in diet, physical activity, alcohol consumption, and tobacco use in adults during the COVID-19 pandemic: a systematic review. Inquiry. 2023;60:00469580231175780. doi:10.1177/00469580231175780
  • Pandey V, Mohan R, Kumar A, Gangadevi P, Kurien N. The impact of the COVID-19 outbreak on lifestyle-related behavior among the general population. Cureus. 2023;15(9):e45756. doi:10.7759/cureus.45756
  • Concepcion J, Yeager M, Alfaro S, et al. Trends of cancer screenings, diagnoses, and mortalities during the COVID-19 pandemic: implications and future recommendations. Am Surg. 2022;14:31348221091948. doi:10.1177/00031348221091948